Why do we need a Catalogue of Services?Currently there are 13 biological and medical sciences in Europe, all of them working jointly together in CORBEL towards offering shared services for life-science.All RIs offer services, i.e. Researchers from academia and industry can access their facilities, technologies and expertise. Services can simply be consultation, access to experts, but also access to data and biological samples, use of data analysis tools, access to facilities (e.g. Highly specialised microscopes) plus support from technicians and much more.The CORBEL Catalogue of Services is the first tool to list the main services of all these RIs at a glance and it aims to facilitate the utilisation of RI services by researchers from all over the world.The Catalogue of Services as displayed below aims to provide you a basic overview on existing services within distinct thematic fields.You can either use the Catalogue of Services to identify a single RI to help you with your work or you can create your own CORBEL service pipelines, i.e.
![]()
Using several RIs subsequently.Examples of service pipelines are provided. In order to improve the catalogue, we kindly ask you to fill in a form.Many thanks! EATRIS supports researchers in translating their findings into novel interventions including preventive, diagnostic or therapeutic products up to clinical proof of concept. The infrastructure comprises over 90 leading research institutions in the translational field located in 12 countries across Europe. EATRIS also supports the validation and development of novel (biological) tools for precision medicine and translational research in drug development. By providing access to accredited facilities as well as market-oriented expertise, including partnering, regulatory and health-technologuy assessment, your validation needs are covered in a one-stop shop.
Services offered by EATRIS include. support funding applications (Identification of partners for consortium building, assessment of the project plan's impact and innovation potential). translational research facilities and expertise for development of novel biomarkers, diagnostics and therapeutics. molecular, functional & hybrid imaging technologies, preclinical models, samples, patient cohorts, GMP manufacturing. regulatory and Health Technology Assessment (HTA) expertise.
advice on intellectual property issues and industry partnering strategy. Translating novel biology insights into effective interventions or medical applications is a highly complex process. It requires significant dedicated expertise, facilities and resources.
2019 iftar saatleri, 2019 sahur saati, imsak vakti, 2019 aksam namazi, iftar vakitleri - namazvakti.net.
We believe in your medical innovation and we want to support you by bringing together the multi-disciplinary expertise and infrastructure required for optimising your translational trajectory. Working with EATRIS gives greater confidence in the translational feasibility of your project and its impact. Countries involved. Difficulties in locating clinical trials units, fulfilling local legal, regulatory and ethical requirements, and coordinating multi-country trial management deter many researchers from attempting multinational trials. This means that most independent trials are conducted in single centres, or multiple centres within one country. ECRIN provides a pathway through Europe's fragmented health and legal systems with its pan-European infrastructure that is designed to support multinational clinical research and unlock access to patients and medical expertise. Countries involved.
The European Marine Biological Research Centre (EMBRC-ERIC) is a Research Infrastructure including 29 Operators across 9 different European countries. EMBRC is dedicated for marine biology and ecology research. EMBRC offers to the scientific community, academic institutions and private companies a comprehensive set of services to study marine organisms and to give access to ecosystems. EMBRC is providing local or remote access to state-of-the-art national facilities such as renowned marine biological stations. The EMBRC service offer includes.
access to ecosystems: coastal research vessels, scientific diving facilities, submersibles (ROV/AUV), in-situ sampling facilities and monitoring equipment, field stations. marine biological resources (micro & macro, alive & fixed, wild & cultivated): biobanks, culture collections (algae, bacteria, zooplankton.
EPPN2020 provides Transnational Access to plant phenotyping infrastructure as a basis for novel scientific approaches to quantitative plant assessment in high thoughput. The installations represent a diverse set of facilities for plant phenotyping in Europe with focus on: i) no-invasive high throughput phenotyping under controlled conditions, ii) destructive sampling aiming at assessing underlying traits helping to understand the genetic variability of different plant processes, iii) controlled field facilities allowing users to control rainfall and/or the concentration of air CO2 together with high-definition non-invasive sensors. Transnational Access will be available based on a simple and transparent access procedure. Countries involved. European Research infrastructure on Highly Pathogenic Agents (ERINHA) is set up to reinforce the European capacities for the study of high consequence pathogens (e.g. Ebola, Lassa, Nipah etc.) and enhance the coordination of Biosafety level 4 and supporting infrastructures. It provides a world-leading high containment capacities and unique expertise and gives access to all interested relevant scientists with large scale research programmes.
ERINHA as a legal entity operates as an AISBL - International non-profit Association under Belgian law. It started its implementation phase from July 2017.
The services offered by ERINHA include. access to state of art European high containment facilities and high consequence pathogens expertise (BSL 4 and connecting infrastructures) to perform research activities (cutting-edge technologies and functions to perform excellence oriented research: e.g.
Epi-fluorescence microscopes, automate for animal biological analysis, cytometry, laminar BSC etc.). project coordination and management of large scale research programmes on high consequence pathogens. training for potential users. advice and scientific expertise provider: RG4 pathogens research, containment facilities construction, biosafety/biosecurity issues, sample transport etc. access to pathogens specimens. The 2014-2015 Ebola outbreak and cases in Europe demonstrated the worldwide vulnerability and need for common action putting together rare high containment capacities and expertise to be able to increase European and global preparedness for outbreaks of high consequence pathogens. ERINHA facilitates access to required infrastructure capacities thanks to its CCU and multiple high containment and complementary European resources.
It is a unique coordinated infrastrucuture providing transnational access to its facilities, large scope of services and shorter delays in access. Countries involved. EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection, comprising up to 140.000 commercial and proprietary compounds collected from European chemists. EU-OPENSCREEN offers to researchers from academic institutions, SMEs and industrial organisations open access to its shared resources.EU-OPENSCREEN will collaboratively develop novel molecular tool compounds with external users from various disciplines of the life sciences. The majority of scientists in Europe do not have access to suitable technology platforms and compound collections, which are generally expensive to purchase, operate and maintain. As a large-scale research infrastructure (RI) with an ‘open’ pre-competitive character, EU-OPENSCREEN will cost-effectively overcome this limitation by: involving and providing access to Europe’s leading screening platforms and chemistry groups; offering a jointly used rationally designed compound collection; and operating an open-access bioactivity database which will be accessible on a global basis. EU-OPENSCREEN offers to support you through grant application processes and beyond for funding involving screening projects.
Countries involved. Euro-BioImaging (EuBI) provides open physical user access to a broad range of state-of-the-art imaging technologies for life scientists in Europe and beyond. In the future, it also will offer image data support and training for infrastructure users and providers and continuously evaluate and include new imaging technologies to ensure cutting-edge services in a sustainable manner.Through Euro-BioImaging (EuBI), researchers can have access to imaging instruments, receive expert technical assistance and support both with project planning and during project execution. In the future, EuBI will offer image data support and training for infrastructure users and providers. Since May 2016, EuBI has opened its doors to the scientific community with the start of Interim Operation.
This means that all researchers at any stage of their career can now request access to 36 imaging technologies hosted at 28 EuBI Node Candidates (specialized imaging facilities hosting the technology and expertise) located in 11 European countries and at EMBL. The access fees for each visit are individually discussed and agreed upon directly between the EuBI user and the respective EuBI Node Candidate as part of the pre-visit discussion during the project planning phase. Thereby, the user is fully informed and aware of all costs that will arise related to the access to a EuBI Node Candidate.
The EuBI Hub Candidates, taking care of all administrative work in EuBI, do not charge any costs to the users!EuBI users can be supported by funded access programs such as iNEXT. Further funding opportunities will be announced on the website.
Access modes. For many researchers coming from various scientific fields, access to high-end imaging technologies is a big plus and provides substantial advantage for their research. Life-cell imaging, electron microscopy and medical imaging, multi-modal molecular imaging, high-throughput or super-resolution microscopy – there are plenty of technologies at Euro-BioImaging that can be exploited.After a simple and straightforward application process, your project proposal is evaluated based on its scientific merit and its technical feasibility. After approximately three weeks, you will receive the result of this evaluation process, and, if successful, you are invited to immediately start planning your visit to your requested imaging facility – the so called EuBI Node Candidate - together with highly trained staff working in this facility. Throughout all project phases, from the planning to the execution and the data analysis, you can profit from the expert support provided by the Node Candidates. Countries involved.
ISBE empowers European researchers across academia, clinics and industry to implement systems biology approaches addressing how the dynamic interactions between biological components (molecules, cells, tissues, organs) leads to the functioning of living organisms. ISBE fosters project collaborations between experimental and computational teams, and with complementary research infrastructures. ISBE actively supports scientists in facilitating model-compliant data generation, making their research assets FAIR (i.e. Findable, accessible, interoperable, and reusable) and creating predictive computational multi-scale models of biological systems based on integration of highly diverse data sets. In addition, ISBE will provide training for infrastructure users and providers to offer efficient services. Services offered by ISBE include.
support to develop and exploit quantitative and predictive computational models to understand the functioning of complex biological systems. support in the acquisition of selected experimental data that are fit-for-modelling. model-based data integration and data analysis (e.g. Cancer cell multiOMICS). model analysis and validation.
model-based simulation. support to implement tools and standards that make research assets FAIR (Findable, Accessible, Interoperable and Reusable) through the FAIRDOM organisation.
training and education. Systems biology is a branch of the life sciences that helps to obtain in-depth understanding through integrating multiple and diverse data sets in quantitative computational models.
These models are able to predict the behaviour of biological systems based on experimental data about the interplay of molecules, cells and tissues in time and space. Validation and analysis of such predictions improve the model and gives insight into the interplay of system components in time and space.
The success of this approach is illustrated with a number of. Countries involved. MIRRI services comprise. access to microorganisms/cell lines deposited in public collections. deposit of microorganisms/cell lines (public collection/patents). phenotypic/molecular characterisation of microorganisms. identification/molecular typing of microorganisms.
isolation/cultivation/preservation of microorganisms. microbial community analyses. microbial phylogenetic studies. screening/bioassays with microorganisms. access to microbiological databases.
consultancy/contract research. legal issues (e.g. Nagoya Protocol). biosafety/biosecurity. training.
MIRRI offers not only a broad spectrum of high quality microorganisms, but also a longlasting expertise in each field of microbiology. Aiming at harmonising the current microbial Biological Resource Centre (mBRC) landscape, MIRRI enables facilitated access to deposited microorganisms and is constantly improving the corresponding state-of-the-art service offers. Our experts ensure legal compliance of resources (Nagoya Protocol) and with the envisaged interoperability of existing and future databases researchers can exploit the full value of microorganisms. Countries involved.
Comments are closed.
|
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |